Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Pfizer
 More »

  • GEN's List of Molecular Millionaires
    ... chairman. The CEOs of two other pharma giants-Joseph Jimenez of Novartis and Ian C. Read of Pfizer-narrowly missed the top 40. For a more complete listing with notes, click here .
    10-15-2013
  • FDA Speeds Things Up
    Breakthrough Therapy Designation Is Changing How the Agency Operates The Food and Drug Administration Safety and Innovation Act (FDASIA) was signed into law on July 9, 2012. FDASIA ...
    10-1-2013
  • Malvern Instruments Acquires NanoSight
    As of May, NanoSight had installed more than 600 systems worldwide for customers that include pharma giants such as GlaxoSmithKline, Merck & Co., Novartis, Pfizer, and Roche, as ...
    9-30-2013
  • Pfizer Licenses Gliknik's GL-2045 in $25M+ Deal
    Pfizer will license Gliknik's preclinical lead recombinant stradomer(tm) GL-2045 for ... to develop GL-2045 for all indications, Pfizer will pay Gliknik $25 million up front. ...
    9-30-2013
  • Takeover Targets: Who Is First on the List?
    ... crafting of ADC licensing agreements with 12 biopharmas-including giants like AbbVie, Bayer, Genentech, GSK, and Pfizer-which have generated more than $225 million for the company. ...
    9-24-2013
  • Sanofi Opens Cancer Research Hub in Cambridge, MA
    Sanofi is one of several biopharma giants that are expanding in Massachusetts: Novartis, Pfizer, and Vertex Pharmaceuticals are set to open new sites over the next year. The sites ...
    9-20-2013
  • Google Eyes Wider Healthcare Footprint with Tech-Focused Calico
    And Sergey Brin, a co-founder of Google, is funding a collaboration between Pfizer and GlaxoSmithKline to develop a new class of medicines designed to slow down the progress of ...
    9-19-2013
  • Top 40 Molecular Millionaires
    ... The CEOs of two other pharma giants-Joseph Jimenez of Novartis, and Ian C. Read of Pfizer-... The CEOs of two other pharma giants-Joseph Jimenez of Novartis, and Ian C. Read of Pfizer-...
    9-19-2013
  • JobWatch: Praying for a Massachusetts Miracle
    South Boston waterfront; and new Cambridge, MA, sites for Biogen Idec, Novartis, and Pfizer. "Some of the expansion we thought we'd see reflected in the 2012 numbers didn't quite ...
    9-18-2013
  • Open-Source Tools for Representing Macromolecules
    HELM technology, originally developed by Pfizer, is being shared via open-source tools-a software toolkit that includes the functionality needed to implement a HELM-based system, ...
    9-15-2013
  • MJFF Forms Research Tool Development Consortium for Parkinson...
    Biogen Idec, Eli Lilly and Co., Pfizer, PsychoGenics, and Upsher-Smith ... ApoPharma, Biogen Idec, Eli Lilly, Pfizer, PsychoGenics, and Upsher-Smith ...
    9-13-2013
  • Cellceutix Scoops Up Bankrupt PolyMedix
    Cellceutix said today it won approval from the U.S. Bankruptcy Court for the District of Delaware to acquire substantially all assets of PolyMedix for just under $5 million, five ...
    9-9-2013
  • As Big Deals Resurface, Who's Next to the Altar?
    ... He cited the company's antibody-drug conjugate licensing agreements with 12 biopharmas-including giants such as AbbVie, Bayer, Genentech, GlaxoSmithKline, and Pfizer-that have ...
    9-9-2013
  • Karo Wins First Milestone for Autoimmune Disease Deal with Pfizer
    A success in the collaboration between Karo Bio and Pfizer to develop novel small molecule ... Under the deal, which began in December 2011, Pfizer agreed to provide full funding for ...
    9-5-2013
  • Capsugel Nabs Bend Research
    He added that the purchase of Bend Research highlighted Capsugel's commitment to investment and strategic growth in the two years since Pfizer sold off what had been one of its ...
    9-5-2013
  • More »

    Journal Articles

  • Surgical Infections Official Journal of the Surgical Infection...

    Surgical Infections
    Surgical Infections Official Journal of the Surgical Infection Society and the Surgical Infection Society-Europe gratefully acknowledges the support from PFIZER U.S. ...
  • Business Process Flow Diagrams in Tissue Bank Informatics System...
    Sandra A. McDonald, Elizabeth Velasco, Nicholas T. Ilasi
    Biopreservation and Biobanking
    Biopreservation and Biobanking Pfizer, Inc.'s Tissue Bank, in conjunction with Pfizer's BioBank (biofluid repository), endeavored to create an overarching internal software package ...
  • Successful Use of Vaginal Sildenafil Citrate in Two Infertility...
    Michael Zinger, James H. Liu, Michael A. Thomas
    Journal of Women's Health
    Successful Use of Vaginal Sildenafil Citrate in Two Infertility Patients with Asherman's Syndrome Journal of Women's Health Vaginal sildenafil citrate (Viagra, Pfizer, Inc., New ...
  • Sunitinib Inhibits MEK/ERK and SAPK/JNK Pathways and Increases...
    Mike S. Fenton, Kenneth M. Marion, Andrew K. Salem, Rachel Hogen, Faramarz Naeim, Jerome M. Hershman
    Thyroid
    Sunitinib Inhibits MEK/ERK and SAPK/JNK Pathways and Increases Sodium/Iodide Symporter Expression in Papillary Thyroid Cancer Thyroid Background: Sunitinib malate (Sutent®, Pfizer...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll